Repurposing dasatinib for diffuse large B cell lymphoma

To repurpose compounds for diffuse large B cell lymphoma (DLBCL), we screened a library of drugs and other targeted compounds approved by the US Food and Drug Administration on 9 cell lines and validated the results on a panel of 32 genetically characterized DLBCL cell lines. Dasatinib, a multikinas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Proc Natl Acad Sci U S A
Autors principals: Scuoppo, Claudio, Wang, Jiguang, Persaud, Mirjana, Mittan, Sandeep K., Basso, Katia, Pasqualucci, Laura, Rabadan, Raul, Inghirami, Giorgio, Grandori, Carla, Bosch, Francesc, Dalla-Favera, Riccardo
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2019
Matèries:
Biological Sciences
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6708382/
https://ncbi.nlm.nih.gov/pubmed/31383760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1905239116
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars